The substance contained in green tea may become another tool for the treatment of patients with chronic lymphocytic leukemia (CLL). Researchers from the Mayo Clinic conduct the second phase of study of substance called epigallocatechin gallate (EGCG), also known as Epigallocatechin 3-gallate.